{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:48:37Z","timestamp":1790747317104,"version":"4.1.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00014","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T04:24:58Z","timestamp":1548735898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["CD56dim CD16\u2212 Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-\u03b1"],"prefix":"10.3389","volume":"10","author":[{"given":"Lazar","family":"Vujanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chuckran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy A.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Mashadi-Hossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa H.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s40265-014-0234-4","article-title":"Nivolumab: a review of its use in patients with malignant melanoma","volume":"74","author":"Deeks","year":"2014","journal-title":"Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"New Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"New Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","article-title":"Dendritic cells in cancer: the role revisited","volume":"45","author":"Veglia","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-065X.2010.00979.x","article-title":"Therapeutic cancer vaccines: are we there yet?","volume":"239","author":"Klebanoff","year":"2011","journal-title":"Immunol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1056\/NEJMoa1012863","article-title":"gp100 Peptide vaccine and interleukin-2 in patients with advanced melanoma","volume":"364","author":"Schwartzentruber","year":"2011","journal-title":"New Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e91438","DOI":"10.1172\/jci.insight.91438","article-title":"Twelve-year survival and immune correlates in dendritic cell\u2013vaccinated melanoma patients","volume":"2","author":"Gross","year":"2017","journal-title":"JCI Insight"},{"key":"B9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/CJI.0b013e31816a8910","article-title":"Adenovirus MART-1\u2013engineered autologous dendritic cell vaccine for metastatic melanoma","volume":"31","author":"Butterfield","year":"2008","journal-title":"J Immunother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00262-008-0533-2","article-title":"Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus","volume":"581","author":"Vujanovic","year":"2009","journal-title":"Cancer Immunol Immunother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4161\/onci.18628","article-title":"Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity","volume":"1","author":"Blalock","year":"2012","journal-title":"Oncoimmunology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF01489488","article-title":"Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells","volume":"15","author":"Jewett","year":"1995","journal-title":"J Clin Immunol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.160.3.1139","article-title":"Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic t cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-\u03b1","volume":"160","author":"T\u00fcting","year":"1998","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1043-4666(03)00226-6","article-title":"IFN\u03b1 regulates NK cell cytotoxicity through STAT1 pathway","volume":"23","author":"Liang","year":"2003","journal-title":"Cytokine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1089\/jir.1993.13.247","article-title":"Interferon\u2013a major regulator of natural killer cell-mediated cytotoxicity","volume":"13","author":"Reiter","year":"2009","journal-title":"J Interferon Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"New Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.4049\/jimmunol.178.7.4011","article-title":"NK cells and cancer","volume":"178","author":"Zamai","year":"2007","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1182\/blood-2009-08-240325","article-title":"Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15","volume":"116","author":"Vujanovic","year":"2010","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/icb.2013.98","article-title":"Natural cytotoxicity receptors and their ligands","volume":"92","author":"Kruse","year":"2013","journal-title":"Immunol Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues","volume":"16","author":"Bj\u00f6rkstr\u00f6m","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"key":"B22","first-page":"279","article-title":"Role of natural killer cells in cancer","volume":"12","author":"Pross","year":"1993","journal-title":"Nat Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"NK cells and cancer immunosurveillance","volume":"27","author":"Waldhauer","year":"2008","journal-title":"Oncogene"},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/bjc.1979.147","article-title":"Low natural-killer-cell activity in familial melanoma patients and their relatives","volume":"40","author":"Hersey","year":"1979","journal-title":"Br J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0165-2478(86)90117-3","article-title":"Surface markers of NK cells in peripheral blood of patients with cirrhosis and hepatocellular carcinoma","volume":"13","author":"Nakajima","year":"1986","journal-title":"Immunol Lett."},{"key":"B26","first-page":"869","article-title":"Natural killer cell activity and head and neck cancer: a clinical assessment","volume":"77","author":"Schantz","year":"1986","journal-title":"J Natl Cancer Inst."},{"key":"B27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF01806249","article-title":"Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity","volume":"7","author":"Strayer","year":"1986","journal-title":"Breast Cancer Res Treat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.humpath.2011.02.019","article-title":"Association between natural killer cells and regression in melanocytic lesions","volume":"42","author":"McKay","year":"2011","journal-title":"Human Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-11-2544","article-title":"Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity","volume":"72","author":"Pietra","year":"2012","journal-title":"Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e76928","DOI":"10.1371\/journal.pone.0076928","article-title":"Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages","volume":"8","author":"Fregni","year":"2013","journal-title":"PLOS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1038\/ncomms6639","article-title":"Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients","volume":"5","author":"Ali","year":"2014","journal-title":"Nat Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4161\/onci.19788","article-title":"Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8\/IL-8 and CXCL10\/IP-10","volume":"1","author":"Vujanovic","year":"2012","journal-title":"Oncoimmunology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e954501","DOI":"10.4161\/21624011.2014.954501","article-title":"Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8+ T-cell responses","volume":"3","author":"Vujanovic","year":"2014","journal-title":"OncoImmunology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/cncr.10775","article-title":"Immunomodulatory effects of high-dose and low-dose interferon \u03b12b in patients with high-risk resected melanoma","volume":"95","author":"Kirkwood","year":"2002","journal-title":"Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00915477","article-title":"Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX The quantitation of natural killer cell activity","volume":"1","author":"Pross","year":"1981","journal-title":"J Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucl Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.4049\/jimmunol.0803523","article-title":"Regulation of NK cell function by human granulocyte arginase","volume":"182","author":"Oberlies","year":"2009","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/01.aids.0000196170.57927.e1","article-title":"Elevated levels of serum perforin in chronic HIV-1 and acute SIV\/SHIV infection","volume":"20","author":"Klingstr\u00f6m","year":"2006","journal-title":"AIDS"},{"key":"B41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/INF.0000000000000530","article-title":"Evaluation of serum perforin, caspase-3, sFasL and M-30 levels as apoptotic markers in children with Crimean-Congo hemorrhagic fever","volume":"34","author":"G\u00fcven","year":"2015","journal-title":"Pediatr Infect Dis J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non\u2013major histocompatibility complex\u2013restricted tumor cell lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"J Exp Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1189\/jlb.0103019","article-title":"G protein-coupled receptors in natural killer cells","volume":"74","author":"Maghazachi","year":"2003","journal-title":"J Leukoc Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.celrep.2016.05.095","article-title":"NKp80 defines a critical step during human natural killer cell development","volume":"16","author":"Freud","year":"2016","journal-title":"Cell Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"12171","DOI":"10.1038\/ncomms12171","article-title":"Human NK cell development requires CD56-mediated motility and formation of the developmental synapse","volume":"7","author":"Mace","year":"2016","journal-title":"Nat Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1038\/s41598-018-21443-5","article-title":"Distinguishing human peripheral blood NK Cells from CD56dimCD16dimCD69+CD103+ resident nasal mucosal lavage fluid cells","volume":"8","author":"Rebuli","year":"2018","journal-title":"Sci Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2017.00760","article-title":"NK cell exhaustion","volume":"8","author":"Bi","year":"2017","journal-title":"Front Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.166.11.6477","article-title":"Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire","volume":"166","author":"Campbell","year":"2001","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"B53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J Leukocyte Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2012.00344","article-title":"Mapping of NKp46(+) cells in healthy human lymphoid and non-lymphoid tissues","volume":"3","author":"Tomasello","year":"2012","journal-title":"Front Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.4049\/jimmunol.177.11.7833","article-title":"Evidence for NK cell subsets based on chemokine receptor expression","volume":"177","author":"Berahovich","year":"2006","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1189\/jlb.0802386","article-title":"A novel epitope of N-CAM defines precursors of human adherent NK cells","volume":"76","author":"Li","year":"2004","journal-title":"J Leukoc Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fimmu.2016.00656","article-title":"Human NK cell subsets in pregnancy and disease: toward a new biological complexity","volume":"7","author":"Cristiani","year":"2016","journal-title":"Front Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3389\/fimmu.2017.00699","article-title":"Human CD56dimCD16dim cells as an individualized natural killer cell subset","volume":"8","author":"Amand","year":"2017","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/sj.leu.2404499","article-title":"CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases","volume":"21","author":"Grzywacz","year":"2007","journal-title":"Leukemia"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","article-title":"NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)","volume":"121","author":"Romee","year":"2013","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"\u201cNatural\u201d killer cells in the mouse. I Cytotoxic cells with specificity for mouse Moloney leukemia cells Specificity and distribution according to genotype","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol."},{"key":"B62","first-page":"363","article-title":"Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients","volume":"42","author":"Hersey","year":"1982","journal-title":"Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1615\/CritRevOncog.2014011142","article-title":"NK cells in the tumor microenvironment","volume":"19","author":"Larsen","year":"2014","journal-title":"Crit Rev Oncogenesis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1182\/blood-2010-09-303057","article-title":"Dissecting CD56dim human NK cells","volume":"116","author":"Moretta","year":"2010","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T07:30:31Z","timestamp":1694590231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2019.00014"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00014","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"article-number":"14"}}